Get started
Author

Jeremy S. Hayllar

Observed names: Hayllar, Jeremy, J Hayllar, J S Hayllar, J. HAYLLAR, J. Hayllar, J.S. Hayllar, Jeremy Hayllar
Observed institutions: Queensland Health, University of Alberta, King's College London, University of Washington, Northwick Park Hospital, Birmingham General Hospital, King's College School, Prince Charles Hospital, St Mark's Hospital, Metro North Hospital and Health Service, Medical Research Council
ORCID: 0000-0003-3065-7591
Observed ORCID: 0000-0003-3065-7591
OpenAlex ID: A5006608189
Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans
1993 · Ingvar Bjarnason, Jeremy Hayllar, et al. · Gastroenterology · 1,026
PDF
Mitochondrial damage: a possible mechanism of the “topical” phase of NSAID induced injury to the rat intestine
1997 · S Somasundaram, S Rafi, et al. · Gut · 313
PDF
Intestinal permeability and inflammation in patients on NSAIDs
1998 · G Sigthorsson, J Tibble, et al. · Gut · 192
Metronidazole reduces intestinal inflammation and blood loss in non-steroidal anti-inflammatory drug induced enteropathy.
1992 · I Bjarnason, J Hayllar, et al. · Gut · 185
PDF
Evaluation of the Xpert HCV Viral Load Finger-Stick Point-of-Care Assay
2018 · Francois M J Lamoury, Sahar Bajis, et al. · The Journal of Infectious Diseases · 128
PDF
Acceptability and preferences of point-of-care finger-stick whole-blood and venepuncture hepatitis C virus testing among people who inject drugs in Australia
2018 · Sahar Bajis, Lisa Maher, et al. · International Journal of Drug Policy · 88
NSAIDs, Cox-2 inhibitors, and the gut
1995 · Jeremy Hayllar, Ingvar Bjarnason · The Lancet · 87
PDF
Progress Towards Elimination of Hepatitis C Infection Among People Who Inject Drugs in Australia: The ETHOS Engage Study
2020 · Heather Valerio, Maryam Alavi, et al. · Clinical Infectious Diseases · 82
Nonsteroidal antiinflammatory drug‐induced small intestinal inflammation and blood loss. Effects of sulfasalazine and other disease‐modifying antirheumatic drugs
1994 · Jeremy Hayllar, Terry Smith, et al. · Arthritis & Rheumatism · 74
NSAIDs, Cox-2 inhibitors, and the gut
1995 · Jeremy Hayllar, Ingvar Bjarnason · The Lancet · 69
A Randomized, Double-Blind, Crossover Comparative Endoscopy Study on the Gastroduodenal Tolerability of a Highly Specific Cyclooxygenase-2 Inhibitor, Flosulide, and Naproxen
1997 · I. Bjarnason, A. Macpherson, et al. · Scandinavian Journal of Gastroenterology · 58
Sulphasalazine in ulcerative colitis: in memoriam?
1991 · J Hayllar, I Bjarnason · Gut · 53
PDF
Hepatitis C virus testing, liver disease assessment and treatment uptake among people who inject drugs pre‐ and post‐universal access to direct‐acting antiviral treatment in Australia: The LiveRLife study
2019 · Sahar Bajis, Jason Grebely, et al. · Journal of Viral Hepatitis · 52
An overview of take‐home naloxone programs in Australia
2018 · Robyn Dwyer, Anna Olsen, et al. · Drug and Alcohol Review · 52
PDF
A three year prospective audit of 212 presentations to the emergency department after electrical injury with a management protocol
2002 · N Blackwell, J Hayllar · Postgraduate Medical Journal · 49
PDF
Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs: The ETHOS Engage study
2022 · Heather Valerio, Maryam Alavi, et al. · International Journal of Drug Policy · 44
Gastroprotection and Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Rationale and Clinical Implications
1992 · Jeremy Hayllar, Andrew Macpherson, et al. · Drug Safety · 30
Gastro-duodenal Damage Due to Non-steroidal Anti-inflammatory Drugs in Children
1993 · R. HERMASZEWSKI, J. HAYLLAR, et al. · Rheumatology · 29
‘I just thought that was the best thing for me to do at this point’: Exploring patient experiences with depot buprenorphine and their motivations to discontinue
2023 · Simon Clay, Carla Treloar, et al. · International Journal of Drug Policy · 27
A Testing Campaign Intervention Consisting of Peer-Facilitated Engagement, Point-of-Care HCV RNA Testing, and Linkage to Nursing Support to Enhance Hepatitis C Treatment Uptake among People Who Inject Drugs: The ETHOS Engage Study
2022 · Anna Conway, Heather Valerio, et al. · Viruses · 22
PDF
Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia: The ETHOS Engage study
2021 · A. Conway, H. Valerio, et al. · International Journal of Drug Policy · 19
General practitioner attitudes to prescribing hepatitis C antiviral therapy in a community setting
2011 · Stephen M. Lambert, Andrew N. Page, et al. · Australian Journal of Primary Health · 19
Early pathogenic events in NSAID-induced gastrointestinal damage.
1996 · I Bjarnason, J Hayllar · PubMed · 19
Factors associated with experiencing stigma, discrimination, and negative health care treatment among people who inject drugs
2024 · Timothy R. Broady, Heather Valerio, et al. · International Journal of Drug Policy · 18
Prevalence and factors associated with hospitalisation for bacterial skin infections among people who inject drugs: The ETHOS Engage Study
2022 · Alice Wheeler, Heather Valerio, et al. · Drug and Alcohol Dependence · 17
Works count: 52
Citation count: 2,847
H-index: 20
I10-index: 29
Year
Topic
Type